Clinical Trials
Learn More
AVAX's International
Subsidiary
www.genopoietic.fr
Patient information on
AVAX's Phase III
Registration Study MVALDI
Clinical News
AVAX's Phase III Registration Study: MVALDI AVAX Technologies Launches Global Phase III Registration Clinical Trial of MVax in Metastatic Melanoma
AVAX Technologies Announces Special Protocol Assessment Agreement with FDA for a Phase III Clinical Trial of MVax in Metastatic Melanoma
© 2008 AVAX Technologies, Inc. | Terms
Site design: Schenkel/Stegman